STUDI IN SILICO SENYAWA EUGENOL CENGKEH (Syzygium aromaticum L.) TERHADAP RESEPTOR ER-α, ER-β DAN HER-2 PADA KANKER PAYUDARA
Abstract
ABSTRACT
Breast cancer is a malignant tumor that can attack the breast tissue which consists of the mammary glands, mammary gland ducts, and the supporting tissues of the breast. Breast cancer develops from normal cells that undergo proliferative changes. Breast cancer is a type of cancer with the greatest prevalence in women in Indonesia. Estrogen receptor alpha (ER-α), estrogen beta (ER-β) and human epidermal growth factor receptor 2 (HER-2) induced by the hormone estrogen will activate genes that play a role in the growth of breast cancer cells. This study aims to determine the potential results of the interaction of the molecular bonding of clove eugenol compounds to the receptor target in breast cancer. The method used is molecular docking using Autodock Vina software. The results showed that eugenol compounds can interact with ER-α, ER-β, and HER-2 and have the potential as breast anticancer with the best binding affinity based on the observed RMSD value.
Keywords: ER-α, ER-β, HER-2, Eugenol, docking
ABSTRAK
Kanker payudara adalah tumor ganas yang dapat menyerang jaringan payudara yang terdiri dari kelenjar susu, saluran kelenjar susu, dan jaringan penunjang payudara. Kanker payudara berkembang dari sel normal yang mengalami perubahan proliferatif. Kanker payudara adalah jenis kanker dengan prevelensi terbesar pada wanita di Indonesia. Reseptor estrogen alfa (ER-α), estrogen beta (ER-β) dan reseptor faktor pertumbuhan manusia-2 (HER-2) yang diinduksi oleh hormon estrogen akan mengaktifkan gen-gen yang berperan dalam pertumbuhan sel kanker payudara. Penelitian ini bertujuan untuk mengetahui potensi hasil interaksi penambatan molekuler senyawa eugenol cengkeh terhadap target reseptor pada kanker payudara. Metode yang digunakan yaitu penambatan molekuler docking menggunakan perangkat lunak Autodock Vina. Hasil penelitian menunjukan bahwa senyawa eugenol dapat berinteraksi dengan ER-α, ER-β, dan HER-2 dan berpotensi sebagai antikanker payudara dengan binding affinity terbaik didasarkan pada nilai RMSD yang dilihat.
Kata kunci: ER-α, ER-β, HER-2, Eugenol, docking
Full Text:
PDFReferences
Al-Sharif. 2013. Eugenol Triggers Apoptosis in Breast Cancer Cell Through E2F1/Survivin Down Regulation. BMC Cancer. 13: 600.
American Cancer Society. 2017. Breast Cancer Treatment Guideline. Atlanta: American Cancer Society.
Anggorowati, L. 2013. Faktor Resiko Kanker Payudara Wanita. Jurnal Kesehatan Masyarakat. Universitas Negeri Semarang. 8 (2) (2013) 121-126.
Franklin, M. C., Carey, K. D., Vajdos, F.F., Leahy, D. J., Mdevos, A. M., dan Sliwskowski, M. X. 2004. Insight into ErbB signaling from the structure of the ErbB2-pertuzumab complex. Cancer Cell, 5: 317 -28.
Ikeda K, Ogawa S, Tsukui T, Horie-Inoue K, Ouchi Y, Kato S, Muramatsu M, Inoue S. 2004. Protein phosphatase 5 is a negative regulator of estrogen receptor-mediated transcription. Mol Endocrinol 18: 1131-1143.
Ladokun, O. A., Abiola, A., Okikiola, D., and Ayodeji, F. 2018. GC-MS and Molecular Docking Studies of Hunteria umbellata Methanolic extract as a potent anti-diabetic. Elsevier. 13: 1-8.
Louie, G. V., Baiga, T. J., Bowman, M. E., Eduka, T. K., Taylor, J. H., Spassova, S. M., Pichersky, E., Noel, J. P. 2007. Strucutre and Reaction Mechanism of Basil Eugenol Synthase. PLoS ONE 2(10): e993.
Lykkesfeldt, A. E., Madsen, M. W., dan Briand, P. 1994. Altered Expression of Estrogen Regulated Genes in a Tamoxifen Resistant and ICI 164,384 and ICI 182,780 Sensitive Human Breast Cancer Cell Line, MCF7/TAMR-1. Cancer Research, 54: 1587- 1595.
Prianto, H. Rurini, R. Unggul J. W. 2013. Isolasi dan Karakterisasi dari Minyak Bunga Cengkeh (Syzigium aromaticum) Kering Hasil Destilasi Uap. Kimia Student Journal. Universitas Brawijaya Malang. 1(2): 269-275.
Pujiastuti, M. W. dan Sanjaya, I. G. M. 2017. Penentuan Aktivitas Senyawa Turunan Mangiferin Sebagai Antidiabetes Pada Diabetes Melitus Tipe 2 Secara In Silico. UNESA Journal of Chemistry. Volume 6 (3): 172:176.
Ring, A., Dowset, M. 2004. Mechanism of Tamoxifen Resistance. Endocrine Related Cancer, 11: 643-648.
Wind, N. S., dan Holen, I. 2011. Multidrug Resistance in Breast Cancer: From In Vitro Models to Clinical Studies. International Journal of Breast Cancer, 1-10.
DOI: https://doi.org/10.35799/pha.10.2021.35603
Refbacks
- There are currently no refbacks.
Copyright (c) 2021 PHARMACON
![Creative Commons License](http://licensebuttons.net/l/by-nc/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
![]() | Publisher : | ![]() | Cooperation With : |
![Creative Commons License](https://i.creativecommons.org/l/by-nc/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.